CritiTech Particle Engineering Solutions (CT PES) is an established, growing, pharmaceutical Contract Research Organization (CRO) and Contract Development Manufacturing Organization (CDMO) with extensive experience and expertise in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing. The company utilizes Spray Drying and Supercritical Precipitation to help its customers develop their drugs. CT PES provides its drug development and manufacturing services from proof-of-concept through Phase II cGMP production. It has produced cGMP materials related to four drugs that are currently being tested in a total of six clinical trials. Clients range from three “Top 15” pharmaceutical companies to pharmaceutical and biotechnology start-ups.

• Experts in solubility and bioavailability enhancement
• Proven track record – developed and produced multiple drugs for numerous Phase II trials
• Rapid project turnaround times
• Highly skilled, professional, and experienced technical staff
• In-house QA/QC unit
• Unwavering commitment to complete customer satisfaction